MorphoSys AG
MPSYF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $2,535,657 | $1,418,822 | $868,457 | $935,664 |
| - Cash | $131,257 | $158,500 | $187,836 | $184,328 |
| + Debt | $261,037 | $635,932 | $282,516 | $281,120 |
| Enterprise Value | $2,665,437 | $1,896,254 | $963,137 | $1,032,456 |
| Revenue | $27,540 | $59,078 | $63,800 | $53,165 |
| % Growth | -53.4% | -7.4% | 20% | – |
| Gross Profit | $23,673 | $44,523 | $48,700 | $45,464 |
| % Margin | 86% | 75.4% | 76.3% | 85.5% |
| EBITDA | -$307,290 | $52,280 | -$50,902 | -$42,666 |
| % Margin | -1,115.8% | 88.5% | -79.8% | -80.3% |
| Net Income | -$314,963 | $48,266 | -$119,600 | -$73,967 |
| % Margin | -1,143.7% | 81.7% | -187.5% | -139.1% |
| EPS Diluted | -8.27 | 1.22 | -3.5 | -2.16 |
| % Growth | -777.9% | 134.9% | -62% | – |
| Operating Cash Flow | -$64,427 | -$56,353 | -$33,679 | -$125,966 |
| Capital Expenditures | -$48 | -$691 | -$1,655 | -$102 |
| Free Cash Flow | -$64,475 | -$57,044 | -$35,334 | -$126,068 |